# Study of JK07 in Patients With Chronic Heart Failure

> **NCT06369298** · PHASE2 · RECRUITING · sponsor: **Salubris Biotherapeutics Inc** · enrollment: 282 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** JK07
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06369298
- **Lead sponsor:** Salubris Biotherapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 282 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06369298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06369298, "Study of JK07 in Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06369298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*